Cefpodoxime proxetil – new opportunities in antibacterial therapy of respiratory infections

The purpose of the expert council was to determine the place of cefpodoxime in the ABT algorithms for upper and lower respiratory tract infections and to form a consensus position on its use in clinical practice. Based on the available data, the possibility of including cefpodoxime in national guide...

Full description

Bibliographic Details
Main Authors: Avdeev S.N., Andreeva I.V., Gorelov A.V., Gurov A.V., Dekhnich A.V., Zyryanov S.K., Karpova E.P., Kozlov R.S., Leshchenko I.V., Ovchinnikov A.Yu., Rachina S.A., Ryazantsev S.V., Svistushkin V.M., Sinopalnikov A.I., Stetsiouk O.U.
Format: Article
Language:Russian
Published: Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2023-12-01
Series:Клиническая микробиология и антимикробная химиотерапия
Online Access:https://cmac-journal.ru/publication/2023/4/cmac-2023-t25-n4-p366/cmac-2023-t25-n4-p366.pdf
Description
Summary:The purpose of the expert council was to determine the place of cefpodoxime in the ABT algorithms for upper and lower respiratory tract infections and to form a consensus position on its use in clinical practice. Based on the available data, the possibility of including cefpodoxime in national guidelines for the treatment of rhinosinusitis, acute tonsillopharyngitis, community-acquired pneumonia (CAP), as well as infectious exacerbations of chronic bronchitis (CB) and chronic obstructive pulmonary disease (COPD) is being considered.
ISSN:1684-4386
2686-9586